| Respiratory syncytial virus prefusion F protein vaccine in older adults A Papi, MG Ison, JM Langley, DG Lee, I Leroux-Roels, F Martinon-Torres, ... New England Journal of Medicine 388 (7), 595-608, 2023 | 280 | 2023 |
| Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial KP Perrett, SA Halperin, T Nolan, CM Pancorbo, B Tapiero, ... Vaccine 38 (8), 2095-2104, 2020 | 32 | 2020 |
| Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo … KP Perrett, SA Halperin, T Nolan, AC Martínez, F Martinón-Torres, ... Vaccine 38 (8), 2105-2114, 2020 | 25 | 2020 |
| Respiratory syncytial virus prefusion F protein vaccine is efficacious in older adults with underlying medical conditions RG Feldman, R Antonelli-Incalzi, K Steenackers, DG Lee, A Papi, MG Ison, ... Clinical Infectious Diseases 78 (1), 202-209, 2024 | 16 | 2024 |
| Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular … D Brandon, M Kimmel, SO Kuriyakose, L Kostanyan, N Mesaros Vaccine 36 (42), 6325-6333, 2018 | 16 | 2018 |
| Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first … M Kovac, L Kostanyan, N Mesaros, S Kuriyakose, M Varman Human Vaccines & Immunotherapeutics 14 (8), 1977-1986, 2018 | 15 | 2018 |
| Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons MG Ison, A Papi, E Athan, RG Feldman, JM Langley, DG Lee, ... Clinical Infectious Diseases, ciae010, 2024 | 11 | 2024 |
| Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial F Martinón-Torres, SA Halperin, T Nolan, B Tapiéro, KP Perrett, ... Vaccine 39 (11), 1598-1608, 2021 | 9 | 2021 |
| LB745. Respiratory syncytial virus (RSV) prefusion F protein candidate vaccine (RSVPreF3 OA) is efficacious in adults≥ 60 years of age (YOA) MG Ison, A Papi, JM Langley, DG Lee, I Leroux-Roels, F Martinon-Torres, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1868, 2022 | 7* | 2022 |
| The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus‐associated disease in breakthrough infections in adults≥ 60 … D Curran, S Matthews, ES Cabrera, SN Pérez, LP Breva, M Rämet, ... Influenza and Other Respiratory Viruses 18 (2), e13236, 2024 | 2 | 2024 |
| 280-LB: Efficacy of a Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults with Preexisting Medical Conditions RG FELDMAN, R ANTONELLI INCALZI, K STEENACKERS, DGUN LEE, ... Diabetes 72 (Supplement_1), 2023 | 1 | 2023 |
| Pertussis vaccination during pregnancy: a multi-country randomised placebo-controlled trial assessing immunogenicity and safety of dTpa in mothers and their infants K Perrett, IC Garcia, S Halperin, T Nolan, M Virta, Z Stranak, D Surico, ... BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY 126, 173-174, 2019 | 1 | 2019 |
| Efficacité d’un vaccin du virus respiratoire syncytial avec protéine F pré-fusion (RSVPreF3 OA) chez les adultes âgés avec maladies cardiorespiratoires pré-existantes A Gruber, A Papi, RG Feldman, R Antonelli-Incalzi, K Steenackers, ... Revue des Maladies Respiratoires Actualités 16 (1), 7-8, 2024 | | 2024 |
| EFFICACY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F PROTEIN VACCINE (RSVPREF3 OA) IN OLDER ADULTS WITH PRE-EXISTING MEDICAL CONDITIONS P Matte, R Feldman, RA Incalzi, K Steenackers, D Lee, L Fissette, ... Canadian Journal of Diabetes 47 (7), S160-S161, 2023 | | 2023 |
| EFICÁCIA DE UMA VACINA DE PROTEÍNA F PRÉ-FUSÃO DO VÍRUS SINCICIAL RESPIRATÓRIO (RSVPREF3 OA) EM ADULTOS MAIS VELHOS COM CONDIÇÕES CARDIORRESPIRATÓRIAS COEXISTENTES L Michelin, V Hulstrom, A Papi, RG Feldman, R Antonelli-Incalzi, ... The Brazilian Journal of Infectious Diseases 27, 103095, 2023 | | 2023 |
| Late Breaking Abstract-Efficacy of a respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults with co-existing cardiorespiratory conditions A Papi, RG Feldman, R Antonelli-Incalzi, K Steenackers, DG Lee, MG Ison, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Le vaccin candidat à base de la protéine F de préfusion du virus respiratoire syncitial (VRS) est efficace chez les adultes≥ 60 ans (RSVPreF3) A Gruber, A Papi, JM Langley, DG Lee, I Leroux-Roels, F Martinon-Torres, ... Médecine et Maladies Infectieuses Formation 2 (2), S72, 2023 | | 2023 |
| A Respiratory Syncytial Virus (RSV) Prefusion F Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults≥ 60 Years of Age (YOA) M Ison, A Papi, J Langley, D Lee, I Leroux-Roels, F Martinón-Torres, ... Pneumologie 77 (S 01), Po 65, 2023 | | 2023 |
| Immune Response to DTPa-HBV-IPV/Hib Booster Vaccination in Infants of Mothers who were vaccinated with Tdap Vaccine during the Pregnancy: Follow-up Study of a randomized … F Martinon-Torres, SA Halperin, T Nolan, B Tapiero, KP Perrett, ... Georg thieme verlag kg, 2020 | | 2020 |
| Immunantwort auf die DTPa-HBV-IPV/Hib-Auffrischimpfung bei Kleinkindern von Müttern, die während der Schwangerschaft mit Tdap-Impfstoff geimpft worden waren: Folgestudie einer … F Martinón-Torres, SA Halperin, T Nolan, B Tapiero, KP Perrett, ... Geburtshilfe und Frauenheilkunde 80 (10), FV030, 2020 | | 2020 |
